29273415 24484983 21761566 21422300 19841255 23016689 25861786 34536757 23448472 23425081 21671905 28464209 33174064 19715279 24588614 20568781 27117332 19807094 16973239 34463847 28692379 24503508 19430912 26780565 26491810 23360448 33454858 3101495 - Search Results

Year	Number of Results
2006	1
2009	4
2010	1
2011	2
2012	1
2013	4
2014	3
2015	2
2016	3
2017	3
2018	1
2019	1
2021	1
2022	4

1

Design, synthesis, and opioid activity of arodyn analogs cyclized by ring-closing metathesis involving Tyr(allyl).

Fang WJ, Murray TF, Aldrich JV. Fang WJ, et al. Bioorg Med Chem. 2018 Mar 15;26(6):1157-1161. doi: 10.1016/j.bmc.2017.11.029. Epub 2017 Nov 21. Bioorg Med Chem. 2018. PMID: 29273415 Free PMC article.

2

Mixed κ/μ partial opioid agonists as potential treatments for cocaine dependence.

Bidlack JM. Bidlack JM. Adv Pharmacol. 2014;69:387-418. doi: 10.1016/B978-0-12-420118-7.00010-X. Adv Pharmacol. 2014. PMID: 24484983 Review.

3

Unexpected opioid activity profiles of analogues of the novel peptide kappa opioid receptor ligand CJ-15,208.

Aldrich JV, Kulkarni SS, Senadheera SN, Ross NC, Reilley KJ, Eans SO, Ganno ML, Murray TF, McLaughlin JP. Aldrich JV, et al. ChemMedChem. 2011 Sep 5;6(9):1739-45. doi: 10.1002/cmdc.201100113. Epub 2011 Jul 14. ChemMedChem. 2011. PMID: 21761566 Free PMC article.

4

κ-Opioid receptor inhibition of calcium oscillations in spinal cord neurons.

Kelamangalath L, Dravid SM, George J, Aldrich JV, Murray TF. Kelamangalath L, et al. Mol Pharmacol. 2011 Jun;79(6):1061-71. doi: 10.1124/mol.111.071456. Epub 2011 Mar 21. Mol Pharmacol. 2011. PMID: 21422300 Free PMC article.

5

Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action.

Aldrich JV, Patkar KA, McLaughlin JP. Aldrich JV, et al. Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18396-401. doi: 10.1073/pnas.0910180106. Epub 2009 Oct 19. Proc Natl Acad Sci U S A. 2009. PMID: 19841255 Free PMC article.

6

Dynorphin convertases and their functions in CNS.

Ner J, Silberring J. Ner J, et al. Curr Pharm Des. 2013;19(6):1043-51. doi: 10.2174/1381612811319060006. Curr Pharm Des. 2013. PMID: 23016689 Review.

7

Targeting Itch with Ligands Selective for κ Opioid Receptors.

Cowan A, Kehner GB, Inan S. Cowan A, et al. Handb Exp Pharmacol. 2015;226:291-314. doi: 10.1007/978-3-662-44605-8_16. Handb Exp Pharmacol. 2015. PMID: 25861786 Review.

8

Quantification of kappa opioid receptor ligand potency, efficacy and desensitization using a real-time membrane potential assay.

Zhao Y, Joshi AA, Aldrich JV, Murray TF. Zhao Y, et al. Biomed Pharmacother. 2021 Nov;143:112173. doi: 10.1016/j.biopha.2021.112173. Epub 2021 Sep 15. Biomed Pharmacother. 2021. PMID: 34536757 Free PMC article.

9

Current κ opioid receptor ligands and discovery of a new molecular scaffold as a κ opioid receptor antagonist using pharmacophore-based virtual screening.

Spetea M, Asim MF, Noha S, Wolber G, Schmidhammer H. Spetea M, et al. Curr Pharm Des. 2013;19(42):7362-72. doi: 10.2174/138161281942140105162601. Curr Pharm Des. 2013. PMID: 23448472

10

The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration.

Eans SO, Ganno ML, Reilley KJ, Patkar KA, Senadheera SN, Aldrich JV, McLaughlin JP. Eans SO, et al. Br J Pharmacol. 2013 May;169(2):426-36. doi: 10.1111/bph.12132. Br J Pharmacol. 2013. PMID: 23425081 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results